Phase 1 and Phase 2 Clinical Trials for Next-Generation Coronavirus Vaccines

$15,048,720N01FY2024AINIH

Leidos Biomedical Research, Inc., Frederick MD

Investigators

Kiran Dattacontact

View original record on NIH RePORTER →

Phase 1 and Phase 2 Clinical Trials for Next-Generation Coronavirus Vaccines · GrantIndex